|

COPD Clinical Trials in Alabama

20 recruiting studies across 9 cities

All Trials in Alabama

Phase
Trial Phase Location
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseasePhase 3Athens
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)Phase 2Birmingham
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.Phase 4Birmingham
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseasePhase 2Birmingham
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Phase 3Birmingham
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseasePhase 2/3Birmingham
Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3N/ABirmingham
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDPhase 2Birmingham
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the HospitalN/ABirmingham
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypePhase 3Birmingham
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPDN/ABirmingham
Genetic Variation in IgG in Alpha 1 Antitrypsin DeficiencyPhase 4Birmingham
Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities—Birmingham
Multi-Center Clean Air Randomized Controlled Trial in COPDPhase 3Birmingham
PiMZ Longitudinal Cohort (PiMZ Logic)—Birmingham
SPIROMICS Study of Early COPD Progression (SOURCE)—Birmingham
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the HomeN/ABirmingham
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)Phase 3Foley
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPDPhase 2Mobile
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)Phase 3Sheffield

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.